RE:RE:RE:RE:RE:Split the company?
fredgoodwinson wrote: Yes an exciting vaccine announcement on the 7th of Feb. The timing of the current preclinical trial was contained in the subsequent Financial Statements published on the 29th of April:
'These results have now laid the groundwork for the next phase of the CRA, which is evaluating the Theralase ® COVID-19 vaccine in the ability to prevent animals from contracting COVID-19, when exposed to the virus, which is expected to commence in 2Q2022 and be completed by 4Q2022'
Depending on when the Trial actually started it is possible that it might be completed well before the end of September.
Would be nice if Canada employed a Canadian version of Operation Ward Speed, but for an intranasal option...an option that has yet to be approved & could either be used as a stand-alone vaccine or to boost a previously mRNA-vaccinated individual. By providing additional tissue-level/mucosal immunity, you significantly increase your chance of fully blocking the Covid/Omicron transmission chain. Current & future "injectable" vaccines bypass this critical line of defense & simply end up "variant chasing". Based on currently published data, it appears it's only a matter of time before an intranasal vaccine gets approved imo. Wouldn't mind if you add us Americans too.
Hopefully, PHAC can be the first public entity to pave the way for "any" promising candidate who can demonstrate the potential to fulfill this essential need. But it's no secret the bulk of subsidized monies always seems to funnel its way towards Big Pharma...when they're in play. Regardless of corporate size, interests, wealth or vaccine type, I hope PHAC can fully honor its mission & "show us the money" if dictated by the science....in order "To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health". Wouldn't mind if you add us Americans too : ) JMO...good luck.